1-2 of 2
Lorella Melillo
Close
Sort by
Journal Articles

ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol

Clinical Trials & Observations
Francesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, Valentina Arena, Anna Candoni, Lorella Melillo, Valeria Calafiore, Roberto Cairoli, Paolo de Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Mario Luppi, Saveria Capria, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Maria Antonietta Irno Consalvo, Tiziana Ottone, Serena Lavorgna, Maria Teresa Voso, Paola Fazi, Marco Vignetti, William Arcese, Adriano Venditti
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2510–2516.
https://doi.org/10.1182/bloodadvances.2021005717
Published: 2022
Includes: Supplemental data
Journal Articles

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy

Clinical Trials & Observations
Fabio Efficace, Uwe Platzbecker, Massimo Breccia, Francesco Cottone, Paola Carluccio, Prassede Salutari, Eros Di Bona, Erika Borlenghi, Francesco Autore, Luciano Levato, Olimpia Finizio, Valentina Mancini, Stefano D’Ardia, Richard F. Schlenk, Lorella Melillo, Monica Fumagalli, Walter Fiedler, Germana Beltrami, Nicola Stefano Fracchiolla, Massimo Bernardi, Paola Fazi, Ombretta Annibali, Karin Mayer, Maria Teresa Voso, Marco Vignetti
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4370–4379.
https://doi.org/10.1182/bloodadvances.2021004649
Published: 2021
Includes: Supplemental data